iShares Health Innovation Active ETF (BMED)

Assets	$9.88M
Expense Ratio	0.55%
PE Ratio	25.82
Shares Out	320,000
Dividend (ttm)	n/a
Dividend Yield	n/a
Ex-Dividend Date	n/a
Payout Frequency	n/a
Payout Ratio	n/a

Volume	359
Open	30.74
Previous Close	30.85
Day's Range	30.74 - 30.74
52-Week Low	20.57
52-Week High	32.19
Beta	0.81
Holdings	158
Inception Date	Sep 29, 2020

About BMED

Fund Home Page

The iShares Health Innovation Active ETF (BMED) is an exchange-traded fund that mostly invests in health care equity. The fund is actively managed to invest in global equities in the health sciences industry. BMED was launched on Sep 29, 2020 and is issued by BlackRock.

• Asset Class: Equity
• Category: Health
• Stock Exchange: NYSEARCA
• Ticker Symbol: BMED
• ETF Provider: BlackRock

Top 10 Holdings

29.64% of assets

Name	Symbol	Weight
Johnson & Johnson	JNJ	4.84%
BLK CSH FND TREASURY SL AGENCY	XTSLA	3.56%
Gilead Sciences, Inc.	GILD	3.36%
Edwards Lifesciences Corporation	EW	2.89%
Roche Holding AG	ROG	2.77%
Amgen Inc.	AMGN	2.58%
Merck & Co., Inc.	MRK	2.56%
Biogen Inc.	BIIB	2.40%
Guardant Health, Inc.	GH	2.35%
Novartis AG	NOVN	2.32%

Performance

BMED had a total return of 17.97% in the past year, including dividends. Since the fund's inception, the average annual return has been 3.48%.